The syringe and the needle can become contaminated when infected blood is left behind between uses. This can occur when users draw back their own blood into a syringe and then inject the blood again several times in an attempt to capture and inject all of the drug held in the syringe. This practice, known as "booting," does not occur when users practice intramuscular or subcutaneous injection, known as "skin popping."
Tests have shown that bleach, hydrogen peroxide, and alcohol can kill HIV in a test tube (in vitro). These substances can be effective for cleaning a syringe and needle if the solution fills the syringe completely, but using disinfected syringes and needles is still not as safe as using new, sterile equipment.
The "cooker" is any small container, usually a spoon or a bottle cap, used to dissolve the injectable drug, most often a powder. Contamination may occur when infected blood is pushed out of the needle or syringe into the cooker while a new shot of the drug is being drawn up. If the needle and syringe are effectively sterilized, the cooker will not be contaminated. In the event of cooker contamination, heating the cooker between shots can kill the virus.
Drug users sometimes employ a piece of cotton as a strainer to trap any impurities from the cooker solution. They strain the solution through the cotton as they draw solution into the syringe. Instead of disposing of each piece of cotton immediately after use, a user will sometimes "beat the cotton" with a little
TABLE 9.1
Reported AIDS cases, by sex, age, and transmission category, through 2003
| Males | Females | Total | ||||||||||
| 2003 | Cumulative through 2003a | 2003 | Cumulative through 2003a | 2003 | Cumulative through 2003a | |||||||
| Transmission category | No. | % | No. | % | No. | % | No. | % | No. | % | No. | % |
| Adult or adolescent | ||||||||||||
| Male-to-male sexual contact | 15,859 | 48 | 401,392 | 55 | — | — | — | — | 15,859 | 35 | 401,392 | 45 |
| Injection drug use | 4,866 | 15 | 156,575 | 21 | 2,262 | 20 | 61,621 | 38 | 7,128 | 16 | 218,196 | 24 |
| Male-to-male sexual contact and injection drug use | 1,695 | 5 | 57,998 | 8 | — | — | — | — | 1,695 | 4 | 57,998 | 6 |
| Hemophilia/coagulation disorder | 74 | 0 | 5,130 | 1 | 11 | 0 | 318 | 0 | 85 | 0 | 5,448 | 1 |
| Heterosexual contact | 3,371 | 10 | 40,947 | 6 | 5,234 | 45 | 70,200 | 43 | 8,605 | 19 | 111,147 | 12 |
| Sex with injection drug user | 477 | 1 | 10,930 | 1 | 985 | 9 | 24,148 | 15 | 1,462 | 3 | 35,078 | 4 |
| Sex with bisexual male | 0 | 0 | 0 | 0 | 223 | 2 | 4,402 | 3 | 223 | 0 | 4,402 | 0 |
| Sex with person with hemophilia | 7 | 0 | 80 | 0 | 16 | 0 | 465 | 0 | 23 | 0 | 545 | 0 |
| Sex with HIV-infected transfusion recipient | 24 | 0 | 505 | 0 | 37 | 0 | 705 | 0 | 61 | 0 | 1,210 | 0 |
| Sex with HIV-infected person, | ||||||||||||
| risk factor not specified | 2,863 | 9 | 29,432 | 4 | 3,973 | 34 | 40,480 | 25 | 6,836 | 15 | 69,912 | 8 |
| Receipt of blood transfusion, blood | ||||||||||||
| components, or tissueb | 111 | 0 | 5,219 | 1 | 108 | 1 | 4,076 | 2 | 219 | 0 | 9,295 | 1 |
| Other/risk factor not reported or identifiedc | 7,274 | 22 | 62,217 | 9 | 3,946 | 34 | 27,181 | 17 | 11,220 | 25 | 89,399 | 10 |
| Subtotal | 33,250 | 100 | 729,478 | 100 | 11,561 | 100 | 163,396 | 100 | 44,811 | 100 | 892,875 | 100 |
| Child ( < 13 yrs at diagnosis) | ||||||||||||
| Hemophilia/coagulation disorder | 0 | 0 | 227 | 5 | 0 | 0 | 7 | 0 | 0 | 0 | 234 | 3 |
| Mother with the following risk factor for, | ||||||||||||
| or documented, HIV infection: | 61 | 87 | 4,232 | 88 | 70 | 85 | 4,317 | 95 | 131 | 86 | 8,549 | 91 |
| Injection drug use | 6 | 9 | 1,643 | 34 | 11 | 13 | 1,645 | 36 | 17 | 11 | 3,288 | 35 |
| Sex with injection drug user | 8 | 11 | 784 | 16 | 6 | 7 | 741 | 16 | 14 | 9 | 1,525 | 16 |
| Sex with bisexual male | 0 | 0 | 95 | 2 | 2 | 2 | 102 | 2 | 2 | 1 | 197 | 2 |
| Sex with person with hemophilia | 1 | 1 | 21 | 0 | 0 | 0 | 15 | 0 | 1 | 1 | 36 | 0 |
| Sex with HIV-infected transfusion recipient | 0 | 0 | 11 | 0 | 0 | 0 | 16 | 0 | 0 | 0 | 27 | 0 |
| Sex with HIV-infected person, | ||||||||||||
| risk factor not specified | 18 | 26 | 705 | 15 | 18 | 22 | 737 | 16 | 36 | 24 | 1,442 | 15 |
| Receipt of blood transfusion, blood | ||||||||||||
| components, or tissue | 0 | 0 | 73 | 2 | 0 | 0 | 83 | 2 | 0 | 0 | 156 | 2 |
| Has HIV infection, risk factor not specified | 28 | 40 | 900 | 19 | 33 | 40 | 978 | 21 | 61 | 40 | 1,878 | 20 |
| Receipt of blood transfusion, blood | ||||||||||||
| components, or tissueb | 1 | 1 | 244 | 5 | 1 | 1 | 143 | 3 | 2 | 1 | 387 | 4 |
| Other/risk factor not reported or identifiedd | 8 | 11 | 80 | 2 | 11 | 13 | 98 | 2 | 19 | 13 | 178 | 2 |
| Subtotal | 70 | 100 | 4,783 | 100 | 82 | 100 | 4,565 | 100 | 152 | 100 | 9,348 | 100 |
| Total | 33,320 | 100 | 734,261 | 100 | 11,643 | 100 | 167,961 | 100 | 44,963 | 100 | 902,223 | 100 |
| a Includes persons with a diagnosis of AIDS, reported from the beginning of the epidemic through 2003. Cumulative total includes | 1 person of unknown sex. | |||||||||||
| b AIDS developed in 46 adults/adolescents and 3 children after they received blood that had tested negative for HIV antibodies. AIDS developed in 14 additional adults after they received | ||||||||||||
| tissue, organs, or artificial insemination from HIV-infected donors. Four of the 14 received tissue or organs from a donor who | was negative for HIV antibody at the time of donation. | |||||||||||
| c Includes 36 adults/adolescents who were exposed to HIV-infected blood, body fluids, or concentrated virus in health care, laboratory, | or household settings, as supported by | |||||||||||
| seroconversion, epidemiologic, and/or laboratory evidence. One person was infected after intentional inoculation with HIV-infected blood. For an additional 361 persons who acquired | ||||||||||||
| HIV infection perinatally, AIDS was diagnosed after age 13. These 361 persons are tabulated under the adult/adolescent, not the | pediatric, transmission category. | |||||||||||
| d Includes 5 children who were exposed to HIV-infected blood as supported by seroconversion, epidemiologic, and/or laboratory evidence: 1 child was infected after intentional | ||||||||||||
| inoculation with HIV-infected blood and 4 children were exposed to HIV-infected blood in a household setting. Of the 178 children, 23 had sexual contact with an adult with or at high | ||||||||||||
| risk for HIV infection. | ||||||||||||
water in an attempt to extract the tiniest bit of the drug that may be left in it. The cotton can become infected if the syringe and needle have not been properly sterilized.
Syringes and needles are usually rinsed out before reuse, not necessarily to decontaminate them but to prevent clotting blood from blocking the equipment. If the rinse water does not contain bleach to disinfect the instruments, use and reuse of the same rinse water can also be a source of contamination.
When two drug users share equipment, one positive for HIV, one not, and the equipment is not properly sterilized between uses, the infection can pass from the carrier of HIV to the healthy person. Other blood-borne diseases can follow the same pathway, including Hepatitis B and Hepatitis C viruses, which cause liver disease.
HIV infection caused by sharing drug paraphernalia can pass to others through sexual contact, and it can also pass to newborn children through childbirth and breastfeeding.
TABLE 9.2
Estimated number of deaths from AIDS, by selected characteristics, 1999-2003
| Year of death | ||||||
| 1999 | 2000 | 2001 | 2002 | 2003 | Cumulative through 2003a | |
| Age at death (years) | ||||||
| < 13 | 97 | 51 | 48 | 35 | 29 | 5,103 |
| 13-14 | 18 | 8 | 4 | 11 | 8 | 252 |
| 15-24 | 232 | 216 | 270 | 199 | 229 | 9,789 |
| 25-34 | 3,258 | 2,823 | 2,512 | 2,143 | 1,928 | 142,761 |
| 35-44 | 7,706 | 7,138 | 7,525 | 6,896 | 6,970 | 216,093 |
| 45-54 | 4,994 | 5,203 | 5,548 | 5,737 | 5,964 | 104,064 |
| 55-64 | 1,556 | 1,631 | 1,873 | 1,840 | 2,146 | 33,717 |
| ≥ 65 | 630 | 670 | 743 | 696 | 741 | 12,282 |
| Race/ethnicity | ||||||
| White, not Hispanic | 5,834 | 5,559 | 5,524 | 5,128 | 4,767 | 230,289 |
| Black, not Hispanic | 9,106 | 8,832 | 9,345 | 8,923 | 9,048 | 195,891 |
| Hispanic | 3,341 | 3,162 | 3,435 | 3,274 | 3,915 | 92,370 |
| Asian/Pacific Islander | 113 | 103 | 108 | 94 | 85 | 3,340 |
| American Indian/Alaska Native | 79 | 67 | 83 | 79 | 78 | 1,529 |
| Transmission category | ||||||
| Male adult or adolescent | ||||||
| Male-to-male sexual contact | 6,703 | 6,316 | 6,479 | 6,012 | 6,015 | 257,898 |
| Injection drug use | 4,425 | 4,182 | 4,298 | 4,126 | 4,166 | 107,797 |
| Male-to-male sexual contact and injection drug use | 1,335 | 1,334 | 1,396 | 1,285 | 1,233 | 38,083 |
| Heterosexual contact | 1,403 | 1,417 | 1,585 | 1,526 | 1,644 | 23,080 |
| Otherb | 194 | 204 | 174 | 166 | 140 | 9,846 |
| Subtotal | 14,061 | 13,454 | 13,932 | 13,116 | 13,198 | 436,704 |
| Female adult or adolescent | ||||||
| Injection drug use | 2,051 | 1,925 | 1,985 | 1,956 | 2,056 | 39,848 |
| Heterosexual contact | 2,157 | 2,192 | 2,444 | 2,335 | 2,584 | 37,901 |
| Otherb | 97 | 92 | 92 | 89 | 95 | 4,115 |
| Subtotal | 4,305 | 4,209 | 4,521 | 4,379 | 4,736 | 81,864 |
| Child ( < 13 yrs at diagnosis) | ||||||
| Perinatal | 117 | 72 | 67 | 58 | 78 | 4,961 |
| Otherc | 8 | 5 | 4 | 4 | 5 | 531 |
| Subtotal | 124 | 78 | 71 | 62 | 83 | 5,492 |
| Region of residence | ||||||
| Northeast | 5,698 | 5,294 | 5,344 | 5,015 | 6,140 | 168,213 |
| Midwest | 1,712 | 1,685 | 1,839 | 1,550 | 1,343 | 50,258 |
| South | 7,406 | 7,352 | 7,624 | 7,526 | 7,068 | 178,447 |
| West | 2,952 | 2,681 | 2,817 | 2,520 | 2,588 | 107,767 |
| U.S. dependencies, possessions, and associated nations | 723 | 729 | 900 | 947 | 877 | 19,375 |
| Totald | 18,491 | 17,741 | 18,524 | 17,557 | 18,017 | 524,060 |
| Note: These numbers do not represent reported case counts. Rather, these numbers are point estimates, which result from adjustments of reported case counts. The reported case counts are adjusted for reporting delays and for redistribution of cases in persons initially reported without an identified risk factor. The estimates do not include adjustment for incomplete reporting. | ||||||
| aIncludes persons who died with AIDS, from the beginning of the epidemic through 2003. | ||||||
| bIncludes hemophilia, blood transfusion, perinatal, and risk factor not reported or not identified. | ||||||
| cIncludes hemophilia, blood transfusion, and risk factor not reported or not identified. | ||||||
| dIncludes persons of unknown race or multiple races and persons of unknown sex. Cumulative total includes 640 persons of unknown race or multiple races. Because column totals were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total. | ||||||
User Comments Add a comment…